Canadian contraception consensus--update on Depot Medroxyprogesterone Acetate (dmpa). (Q36507697)

14 August 2017

title

Canadian contraception consensus--update on Depot Medroxyprogesterone Acetate (dmpa). (English)

1 reference

medroxyprogesterone acetate

14 August 2017

1 reference

1 reference

Amanda Black

1

1 reference

14 August 2017

Ad Hoc DMPA Committee of the Society of Obstetricians and Gynaecologists of Canada

series ordinal

2

1 reference

14 August 2017

publication date

1 April 2006

1 reference

Journal of Obstetrics and Gynaecology Canada

14 August 2017

published in

1 reference

14 August 2017

volume

28

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

305-313

1 reference

The 2002 Canadian Contraception Study: part 1.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Experiences of injectable contraceptive users in an urban setting

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Return of fertility in women discontinuing injectable contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Bone density in long term users of depot medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Bone mineral density in adolescent and young adult women on injectable or oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Injectable hormone contraception and bone density: results from a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Bone mineral density in adolescent females using depot medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Changes in bone density with lactation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Standards and Guidelines for Performing Central Dual X-Ray Densitometry from the Canadian Panel of International Society for Clinical Densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932125-9

7 January 2021

10.1016/S1701-2163(16)32125-9

Identifiers

DOI

0 references

1 reference